AI-powered precision oncology techbio platform for drug development.
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Seed French precision-oncology startup Orakl Oncology raised 11M EUR seed led by Singular to launch its O-Predict and O-Validate products. | $11.6M |
| Oct 2023 | Seed France-based Orakl Oncology raised EUR3M led by Speedinvest for its tumour-avatar drug-development platform. | $3.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.